Diacylglycerol Metabolism and Signaling Is a Driving Force Underlying FASN Inhibitor Sensitivity in Cancer Cells

April 17th, 2015 by Daniel I. Benjamin, Daniel S. Li, Wallace Lowe, Timothy Heuer, George Kemble and Daniel K. Nomura

TOC Graphic

ACS Chemical Biology
DOI: 10.1021/acschembio.5b00240
  • Posted in ACS Chemical Biology, Publications
  • Comments Off on Diacylglycerol Metabolism and Signaling Is a Driving Force Underlying FASN Inhibitor Sensitivity in Cancer Cells